Focal nodular hyperplasia: Characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI

British Journal of Radiology

Volumn 86, Issue 1028, 2013, Pages

  Aa, H S ^a   Park, H S ^a   Kim, Y J ^a   Jung, S I ^a   Jeon, H J ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER FIBROSIS; LIVER PARENCHYMA; MALE; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE SCANNER; RETROSPECTIVE STUDY; AGED; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; AGED; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOCAL NODULAR HYPERPLASIA; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84880885654     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20130299     Document Type: Article

References (32)

1. Maillette de Buy Wenniger L, Terpstra V, Beuers U. Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg 2010;27:24-31. doi: 10.1159/000268404.
2. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5:1194-200. (Pubitemid 16222291)
3. Kondo F. Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol 2001; 16:1319-28. (Pubitemid 34107397)
4. Reddy KR, Kligerman S, Levi J, Livingstone A, Molina E, Franceschi D, et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001;67:173-8. (Pubitemid 33738212)
5. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Métreau JM, Meignan M, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995;22:1674-81.
6. Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, et al. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 2012;199:26-34.
7. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005;236: 166-77. doi: 10.1148/radiol.2361040338. (Pubitemid 40853309)
8. Grazioli L, Morana G, Federle MP, Brancatelli G, Testoni M, Kirchin MA, et al. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology 2001;221:731-9. (Pubitemid 33101765)
9. Ferlicot S, Kobeiter H, Tran Van Nhieu J, Cherqui D, Dhumeaux D, Mathieu D, et al. MRI of atypical focal nodular hyperplasia of the liver: radiology-pathology correlation. AJR Am J Roentgenol 2004;182:1227-31. doi: 10.2214/ajr.182.5.1821227. (Pubitemid 38525519)
10. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPAenhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008;43:504-11.
11. Mohajer K, Frydrychowicz A, Robbins JB, Loeffler AG, Reed TD, Reeder SB. Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging 2012;36:686-96. doi: 10.1002/jmri.23701.
12. Purysko AS, Remer EM, Coppa CP, Obuchowski NA, Schneider E, Veniero JC. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodiumenhanced MRI. AJR Am J Roentgenol 2012;198:115-23. doi: 10.2214/AJR.11.6836.
13. Gupta RT, Iseman CM, Leyendecker JR, Shyknevsky I, Merkle EM, Taouli B. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium. AJR Am J Roentgenol 2012; 199:35-43. doi: 10.2214/AJR.11.7757.
14. Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 2012;262:520-9. doi: 10.1148/radiol.11101742.
15. Karam AR, Shankar S, Surapaneni P, Kim YH, Hussain S. Focal nodular hyperplasia: central scar enhancement pattern using Gadoxetate Disodium. J Magn Reson Imaging 2010; 32:341-344. doi: 10.1002/jmri.22262.
16. Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008;246:812-22. doi: 10.1148/radiol.2463070432.
17. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998;170:397-402. doi: 10.2214/ajr.170.2.9456953. (Pubitemid 28083846)
18. Bruegel M, Holzapfel K, Gaa J, Woertler K, Waldt S, Kiefer B, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusionweighted single-shot echo-planar MR imaging technique. Eur Radiol 2008;18:477-85. doi: 10.1007/s00330-007-0785-9. (Pubitemid 351248179)
19. Bammer R. Basic principles of diffusionweighted imaging. Eur J Radiol 2003;45: 169-84.
20. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497-505.
21. Taouli B, Tolia AJ, Losada M, Babb JS, Chan ES, Bannan MA, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 2007;189:799-806. doi: 10.2214/AJR.07.2086. (Pubitemid 47479760)
22. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254: 47-66. doi: 10.1148/radiol.09090021.
23. Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 2008;28:89-95. doi: 10.1002/jmri.21227. (Pubitemid 351956470)
24. Lewin M, Poujol-Robert A, Bo?elle PY, Wendum D, Lasnier E, Viallon M, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007;46:658-65. doi: 10.1002/hep.21747. (Pubitemid 47436110)
25. Koinuma M, Ohashi I, Hanafusa K, Shibuya H. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 2005;22: 80-85. doi: 10.1002/jmri.20344. (Pubitemid 40885132)
26. Agnello F, Ronot M, Valla DC, Sinkus R, Van Beers BE, Vilgrain V. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology 2012;262:511-19. doi: 10.1148/radiol.11110922.
27. Cieszanowski A, Anysz-Grodzicka A, Szeszkowski W, Kaczynski B, Maj E, Gornicka B, et al. Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. Eur Radiol 2012;22:2514-24.
28. Kanematsu M, Goshima S, Watanabe H, Kondo H, Kawada H, Noda Y, et al. Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review. Abdom Imaging 2013;38:297-308. doi: 10.1007/s00261-012-9940-0.
29. Leconte I, Van Beers BE, Lacrosse M, Sempoux C, Jamart J, Materne R, et al. Focal nodular hyperplasia: natural course observed with CT and MRI. J Comput Assist Tomogr 2000;24:61-6.
30. Kuo YH, Wang JH, Lu SN, Hung CH, Wei YC, Hu TH, et al. Natural course of hepatic focal nodular hyperplasia: a long-term follow-up study with sonography. J Clin Ultrasound 2009;37:132-7. doi: 10.1002/jcu.20533.
31. Kwee TC, Takahara T, Koh DM, Nievelstein RA, Luijten PR. Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Mag Reson Imaging 2008;28:1141-8. doi: 10.1002/jmri.21569.
32. Kartalis N, Loizou L, Edsborg N, Segersv?ard R, Albiin N. Optimising diffusion-weighted MR imaging for demonstrating pancreatic cancer: a comparison of respiratorytriggered, free-breathing and breath-hold techniques. Eur Radiol 2012;22:2186-92. doi: 10.1007/s00330-012-2469-3.